Warby Parker Inc. (WRBY) stock analysis
Close on Nov 12, 2026Market cap $3.30BP/E 445.5Yield –
StockData Score
Prices as of Nov 12, 2026How the score works
Mixed12 of 30 checks passed
Warby Parker passes 12 of the 30 checks behind our score; 11 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.
- Valuation
- 0/6
- Growth
- 3/6
- Past performance
- 3/6
- Financial health
- 6/6
- Dividend
- 0/6
What stands out
No debt
Warby Parker has no borrowings on its latest balance sheet.
Revenue growing 10%+ a year
Revenue grew 13.4% a year over the last three fiscal years.
Interest well covered
No meaningful interest expense to cover.
Debt covered by cash flow
There is no debt to cover.
What to watch
Margin of safety under 20%
The price is 187% above fair value, so there is no margin of safety.
Trading above fair value
The share price of $26.73 is above our fair value estimate of $9.32.
Return on equity under 15%
Return on equity was 1.9% over the last twelve months and averaged -78.8% over five years; we look for 15% on both.
Return on capital under 10%
Return on invested capital was 1.1%, below the 10% that usually covers the cost of capital.
Valuation0/6
P/E against its history
Not enough price and earnings history to compare.
P/E above the industry
Warby Parker's P/E of 445.5 is above the Measuring, Analyzing, and Controlling Instruments; Photographic, Medical and Optical Goods; Watches and Clocks median of 30.0.
EV/EBITDA against its history
Needs positive EBITDA and price history.
P/B above the industry
Warby Parker's price-to-book of 8.19 is above the Measuring, Analyzing, and Controlling Instruments; Photographic, Medical and Optical Goods; Watches and Clocks median of 3.19.
Trading above fair value
The share price of $26.73 is above our fair value estimate of $9.32.
Margin of safety under 20%
The price is 187% above fair value, so there is no margin of safety.
Growth3/6
Revenue growing 10%+ a year
Revenue grew 13.4% a year over the last three fiscal years.
EPS growth over 3 years
Needs positive EPS three years ago and today.
Earnings acceleration
Needs positive net income now, a year ago and five years ago.
Growing faster than the industry
Revenue grew 9.9% over the last twelve months; the Measuring, Analyzing, and Controlling Instruments; Photographic, Medical and Optical Goods; Watches and Clocks median is 8.0%.
Guidance issued
The latest outlook (full year 2026 Net revenue, Nov 5, 2026) was issued for the first time, so it neither adds nor takes away points.
Gross margin improving
Gross margin was 54.7% over the last twelve months, against 54.4% a year earlier.
Past performance3/6
Return on equity under 15%
Return on equity was 1.9% over the last twelve months and averaged -78.8% over five years; we look for 15% on both.
Return on capital under 10%
Return on invested capital was 1.1%, below the 10% that usually covers the cost of capital.
Return on equity above the industry
Warby Parker's return on equity of 1.9% is above the Measuring, Analyzing, and Controlling Instruments; Photographic, Medical and Optical Goods; Watches and Clocks median of 1.0%.
Earnings over 5 years
Needs positive net income five years ago and in the latest year.
Net margin above its 5-year average
Net margin was 0.8% over the last twelve months, against a 5-year average of -11.4%.
Net margin above the industry
Warby Parker's net margin of 0.8% is above the Measuring, Analyzing, and Controlling Instruments; Photographic, Medical and Optical Goods; Watches and Clocks median of 0.5%.
Financial health6/6
No debt
Warby Parker has no borrowings on its latest balance sheet.
Debt not rising
With no debt today, leverage cannot have risen.
Debt covered by cash flow
There is no debt to cover.
Interest well covered
No meaningful interest expense to cover.
Short-term assets cover short-term debts
Current assets are 2.26 times current liabilities.
Low bankruptcy risk
The Altman Z-score is 5.41; above 3 is the safe zone and below 1.8 the distress zone.
Dividend0/6
No dividend
Warby Parker has not paid a dividend in the last twelve months.
Yield against Treasuries
No dividend.
Yield against the market
No dividend.
Dividend stability
No dividend.
Earnings cover
No dividend.
Cash-flow cover
No dividend.
Fair value
How we estimate itOur estimate per share
$9.32
The share price is 187% above this estimate.
| Method | Multiple used | Own 5Y median | Industry median | Value per share | Weight |
|---|---|---|---|---|---|
| P/Eleft out, too far from the others | 30.0× | – | 30.0× | $1.80 | – |
| EV/EBITDA | 17.8× | – | 17.8× | $10.52 | 58% |
| P/B | 4.7× | 6.2× | 3.2× | $15.29 | 17% |
| Earnings power | 14.4% cost of equity | – | – | $2.54 | 25% |
| Fair value | $9.32 | 100% | |||
Valuation over time
Using the earnings and balance sheet published at each date, not today's.
- EV/EBITDA at month end
- Measuring, Analyzing, and Controlling Instruments; Photographic, Medical and Optical Goods; Watches and Clocks median 17.8
An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.
Market risk
From the past year of daily prices.
Liquidity
Low risk
- Average value traded per day
- $101.04M
- Value traded per 1% price move
- $27.39M
Downside
Medium risk
- Typical loss in a bad month
- 22.3%
- Volatility (annualized)
- 83%
- Sharpe ratio, 1 year
- 0.59
- Beta to the S&P 500 (5Y)
- 1.89
Typical bad-month loss, week by week
Margins
Share of revenue, fiscal years 2018 to 2025
Gross margin
Operating margin
Net margin
Growth rates
Compound annual growth to fiscal 2025
| Per year | 1 year | 3 years | 5 years | 10 years | Five-year pace |
|---|---|---|---|---|---|
| Revenue | +13.0% | +13.4% | +17.2% | – | |
| Gross profit | +10.2% | +11.3% | +15.2% | – | |
| Free cash flow | +26.0% | – | +28.1% | – |
Returns and balance sheet
8 fiscal years. Hover a measure to see how it is calculated.
| Measure | FY2018 | FY2020 | FY2025 | Trend |
|---|---|---|---|---|
| Return on equity | – | 28.9% | 0.5% | |
| Return on assets | – | – | 0.2% | |
| Current ratio | – | 3.42 | 2.35 | |
| Inventory turnover | – | – | 8.3× | |
| Capex to revenue | – | 5.1% | 7.7% | |
| Diluted shares | – | 53M | 125M |
Where the cash went
Fiscal 2021 to 2025, five years combined
Warby Parker generated $312.88M from operations and spent $301.53M on capital expenditure, dividends and share buybacks. 97% of that went back into the business.
DuPont analysis
Return on equity split into margin, efficiency and leverage
| Fiscal year | Net margin | Asset turnover | Equity multiplier | Return on equity |
|---|---|---|---|---|
| FY2025 | 0.2% | 1.25× | 1.97× | 0.5% |
| FY2024 | -2.6% | 1.23× | 1.96× | -6.4% |
| FY2023 | -9.4% | 1.17× | 1.95× | -21.5% |
| FY2022 | -18.5% | 1.19× | 1.76× | -38.6% |
| FY2021 | -26.7% | 1.22× | 10.07× | -328.3% |
Piotroski F-Score
Nine tests of profitability, balance sheet and efficiency, fiscal 2025 against fiscal 2024
- ProfitableNet income above zero$1.64M
- Cash generatingOperating cash flow above zero$110.79M
- Return on assets improvedROA up on the prior year-3.5% → 0.2%
- Earnings backed by cashOperating cash flow above net income$110.79M vs $1.64M
- Less leverageLong-term debt to assets fell– → –
- Better liquidityCurrent ratio rose2.50 → 2.35
- No dilutionShare count did not rise120M → 125M
- Gross margin improvedGross margin up on the prior year55.34% → 53.97%
- More efficientAsset turnover rose1.33 → 1.29
See a number that looks wrong?